Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
ATLANTA, Aug. 10, 2021 (GLOBE NEWSWIRE) -- DecisionLink, the leader in cloud-based customer value management (CVM), today introduced the first cohort members to complete its Value Black Belt (VBB)...
-
ATLANTA, July 26, 2021 (GLOBE NEWSWIRE) -- DecisionLink today announced that it was named a 2021 Sammys winner in the very small company product of the year category for its ValueCloud® platform,...
-
DecisionLink First to Deliver Value Realization Solution to Improve Customer Retention and Expansion
New tools extend ValueCloud® to customer success, providing unprecedented visibility and insights into customer value achievement; DecisionLink launches first certification program for CVM to ensure...
-
ATLANTA, May 24, 2021 (GLOBE NEWSWIRE) -- DecisionLink, the leader in cloud-based customer value management (CVM), today introduced Tim Page as its new Chief Executive Officer. A highly regarded...
-
ATLANTA, April 22, 2021 (GLOBE NEWSWIRE) -- DecisionLink today announced that it was named one of Atlanta’s fastest growing companies by the Atlanta Business Chronicle’s 2021 Pacesetter Awards....
-
ATLANTA, Ga., April 15, 2021 (GLOBE NEWSWIRE) -- Customer value management trailblazer DecisionLink today unveiled the next generation of ValueCloud®, a significant new release for the industry’s...
-
ATLANTA, March 25, 2021 (GLOBE NEWSWIRE) -- Value Management pioneer DecisionLink today announced that it has completed its SOC 2 Type II audit, performed by KirkpatrickPrice, making it the first...
-
HANCOCK, Md., Aug. 25, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTCQB:PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications and...
-
La Chaux-de-Fonds, Switzerland, Sept. 22, 2015 (GLOBE NEWSWIRE) -- Rhizen Pharmaceuticals S.A. has announced the initiation of Phase 2 study of RV1001, a novel, oral selective inhibitor of PI3K...
-
DENVER, CO--(Marketwire - December 21, 2010) - Recently issued guidance from the Federal Financial Institutions Examination Council (FFIEC) on real estate appraisals and evaluations will have a major...